STEAP4 and metabolic dysfunction-associated steatotic liver disease: A previous study showed that STAMP2 expression in the liver was markedly reduced in non-alcoholic fatty liver disease (NAFLD), which is characterized by lipid accumulation, hepatocellular inflammation, and fibrosis [8].